Globus Medical Inc (NYSE:GMED)
$ 76.49 +1.07 (+1.42%) Market Cap: 10.38 Bil Enterprise Value: 9.87 Bil PE Ratio: 17.79 PB Ratio: 2.19 GF Score: 97/100

Q1 2026 Globus Medical Inc Earnings Call Transcript

May 07, 2026 / 08:30PM GMT
Release Date Price: $85.07 (-4.65%)
Operator

Welcome to Globus Medical's first-quarter 2026 earnings call. (Operator Instructions) Please be advised that today's conference is being recorded.

I will now turn the call over to Brian Kearns, Senior Vice President of Business Development and Investor Relations. Mr. Kearns, please go ahead.

Brian Kearns
Globus Medical Inc - Investor Relations

Thank you, Kathy, and thank you, everyone, for being with us today. Joining today's call from Globus Medical will be Keith Pfeil, President and CEO; and Kyle Kline, Chief Financial Officer. This review is being made available via webcast accessible through the Investor Relations section of the Globus Medical website at www.globusmedical.com.

Before we begin, let me remind you that some of the statements made during this review are or may be considered forward-looking statements.

Our Form 10-K for the 2025 fiscal year and our subsequent filings with the Securities and Exchange Commission identify certain factors that could

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot